S2R
0.13
38.3%
XGLR
0.004
-42.9%
4DX
0.775
36%
ALM
0.005
-28.6%
8CO
0.035
34.6%
MEM
0.003
-25%
AUK
0.004
33.3%
TYX
0.003
-25%
AYT
0.004
33.3%
OMG
0.011
-21.4%
BLU
0.008
33.3%
OEL
0.004
-20%
DRE
0.016
33.3%
PKD
0.028
-17.6%
FRX
0.008
33.3%
BRU
0.02
-16.7%
JAL
0.12
30.4%
ETM
0.07
-16.7%
ILT
0.275
27.9%
OSX
0.01
-16.7%
AHK
0.435
26.1%
TAR
0.01
-16.7%
RUL
4.63
22.8%
IFG
0.031
-16.2%
AGD
0.049
22.5%
DEL
0.13
-16.1%
AZI
0.023
21.1%
TG1
0.028
-15.2%
DAL
0.047
20.5%
AVE
0.006
-14.3%
AHN
0.006
20%
AZL
0.006
-14.3%
AKN
0.006
20%
ENV
0.006
-14.3%
ARV
0.006
20%
LCL
0.006
-14.3%
KAL
0.048
20%
SPX
0.006
-14.3%
RRR
0.096
20%
VHL
0.025
-13.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf